Accuracy of screening strategies for masked hypertension: a large-scale nationwide study based on home blood pressure monitoring

被引:0
作者
Marco A. M. Alves
Audes D. M. Feitosa
Marco A. Mota-Gomes
Annelise M. G. Paiva
Weimar S. Barroso
Roberto D. Miranda
Eduardo C. D. Barbosa
Andréa A. Brandão
Paulo G. S. Diniz
Otavio Berwanger
José L. Lima-Filho
Andrei C. Sposito
Antonio Coca
Wilson Nadruz
机构
[1] Federal University of Pernambuco,Laboratory of Immunopathology Keizo Asami
[2] University of Pernambuco,Pronto Socorro Cardiológico de Pernambuco (PROCAPE)
[3] UNICAP Clinical Research Institute,Hypertension League, Cardiovascular Section
[4] CESMAC University Center/Heart Hospital of Alagoas,Cardiovascular Section, Geriatrics Division, Paulista School of Medicine
[5] Federal University of Goiás,Department of Hypertension and Cardiometabolism
[6] Federal University of São Paulo,School of Medical Sciences
[7] Hospital Israelita Albert Eistein,Academic Research Organization (ARO)
[8] São Francisco Hospital - Santa Casa de Porto Alegre,Department of Internal Medicine, School of Medical Sciences
[9] State University of Rio de Janeiro,Hypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Clinic
[10] Hospital Israelita Albert Einstein,undefined
[11] State University of Campinas,undefined
[12] University of Barcelona,undefined
来源
Hypertension Research | 2023年 / 46卷
关键词
Home blood pressure; Masked hypertension; Screening; Guidelines;
D O I
暂无
中图分类号
学科分类号
摘要
This study compared the ability of guideline-proposed office blood pressure (OBP) screening thresholds [European Society of Hypertension (ESH) guidelines: 130/85 mmHg for individuals with an OBP < 140/90 mmHg; American College of Cardiology/American Heart Association (ACC/AHA) guidelines: 120/75 mmHg for individuals with an OBP < 130/80 mmHg] and novel screening scores to identify normotensive individuals at high risk of having masked hypertension (MH) in an office setting. We cross-sectionally evaluated untreated participants with an OBP < 140/90 mmHg (n = 22,266) and an OBP < 130/80 mmHg (n = 10,005) who underwent home blood pressure monitoring (HBPM) (derivation cohort) from 686 Brazilian sites. MH was defined according to criteria suggested by the ESH (OBP < 140/90 mmHg; HBPM ≥ 135/85 mmHg), Brazilian Society of Cardiology (BSC) (OBP < 140/90 mmHg; HBPM ≥ 130/80 mmHg) and ACC/AHA (OBP < 130/80 mmHg; HBPM ≥ 130/80 mmHg). Scores were generated from multivariable logistic regression coefficients between MH and clinical variables (OBP, age, sex, and BMI). Considering the ESH, BSC, and ACC/AHA criteria, 17.2%, 38.5%, and 21.2% of the participants had MH, respectively. Guideline-proposed OBP screening thresholds yielded area under curve (AUC) values of 0.640 (for ESH criteria), 0.641 (for BSC criteria), and 0.619 (for ACC/AHA criteria) for predicting MH, while scores presented as continuous variables or quartiles yielded AUC values of 0.700 and 0.688 (for ESH criteria), 0.720 and 0.709 (for BSC criteria), and 0.671 and 0.661 (for ACC/AHA criteria), respectively. Further analyses performed with alternative untreated participants (validation cohort; n = 2807 with an OBP < 140/90 mmHg; n = 1269 with an OBP < 130/80 mmHg) yielded similar AUC values. In conclusion, the accuracy of guideline-proposed OBP screening thresholds in identifying individuals at high risk of having MH in an office setting is limited and is inferior to that yielded by scores derived from simple clinical variables.
引用
收藏
页码:742 / 750
页数:8
相关论文
共 163 条
[1]  
Lovibond K(2011)Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study Lancet 378 1219-30
[2]  
Jowett S(2017)ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol 2018 2199-269
[3]  
Barton P(2018)Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension J Hypertens 2018 2284-309
[4]  
Caulfield M(2021)Brazilian Guidelines of Hypertension—2020 Arq Bras Cardiol 116 516-658
[5]  
Heneghan C(2018)Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis Integr Blood Press Control 11 11-24
[6]  
Hobbs FD(2020)Masked hypertension: a systematic review Heart Lung Circ 29 102-11
[7]  
Whelton PK(2019)Masked hypertension: whom and how to screen? Curr Hypertens Rep 21 26-405
[8]  
Carey RM(2007)Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population J Hypertens 25 2398-7
[9]  
Aronow WS(2009)Masked hypertension: different blood pressure measurement methodology and risk factors in a working population J Hypertens 27 1560-8
[10]  
Casey DE(2011)Determinants of masked hypertension in the general population: the Finn-Home study J Hypertens 29 1880-55